Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Scientists have developed a long-awaited anti-malaria medicine designed to counter rising drug resistance in Africa and…

Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Scientists have developed a long-awaited anti-malaria medicine designed to counter rising drug resistance in Africa and…


Dr. Brown: The weight loss supplements I worry about a lot. Kratom I worry about a lot. Turmeric and ashwagandha – because they’re used so frequently and often at such a high dose – we see problems.
Courtney:…

For years, coffee has been surrounded by mixed opinions—is it the ultimate morning energy booster or a reason behind an increased heart rate and anxiety?
However, research published in the European Journal of Preventive Cardiology gives a…

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its…
This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…

James GallagherHealth and science correspondent
Nye familyScientists have discovered why type 1 diabetes is more severe and aggressive when it develops in young children.
Type…

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.